➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
Mallinckrodt
Moodys
Baxter

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DDAVP (NEEDS NO REFRIGERATION)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Ddavp (needs No Refrigeration)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Bill and Melinda Gates Foundation N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Global Network for Women's and Children's Health Research N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Jawaharlal Nehru Medical College N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed John E. Fogarty International Center (FIC) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Cancer Institute (NCI) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Center for Complementary and Integrative Health (NCCIH) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Institute of Dental and Craniofacial Research (NIDCR) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ddavp (needs No Refrigeration)

Condition Name

Condition Name for Ddavp (needs No Refrigeration)
Intervention Trials
Postpartum Hemorrhage 2
Pancreatic Cancer 1
Dental Caries 1
Status Epilepticus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ddavp (needs No Refrigeration)
Intervention Trials
Hemorrhage 4
Postpartum Hemorrhage 3
HIV Infections 2
Wounds and Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ddavp (needs No Refrigeration)

Trials by Country

Trials by Country for Ddavp (needs No Refrigeration)
Location Trials
United States 17
India 4
Brazil 4
Canada 3
Kenya 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ddavp (needs No Refrigeration)
Location Trials
Texas 4
Florida 2
California 1
Rhode Island 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ddavp (needs No Refrigeration)

Clinical Trial Phase

Clinical Trial Phase for Ddavp (needs No Refrigeration)
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2/Phase 3 3
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ddavp (needs No Refrigeration)
Clinical Trial Phase Trials
Completed 11
Recruiting 2
Terminated 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ddavp (needs No Refrigeration)

Sponsor Name

Sponsor Name for Ddavp (needs No Refrigeration)
Sponsor Trials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2
University of Washington 1
Virginia Commonwealth University 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ddavp (needs No Refrigeration)
Sponsor Trials
Other 33
NIH 7
Industry 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Dow
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.